[go: up one dir, main page]

AR055072A1 - Uso de anticuerpos anti- madcam para el tratamiento de enfermedad celiaca y esprue tropical - Google Patents

Uso de anticuerpos anti- madcam para el tratamiento de enfermedad celiaca y esprue tropical

Info

Publication number
AR055072A1
AR055072A1 ARP060102914A ARP060102914A AR055072A1 AR 055072 A1 AR055072 A1 AR 055072A1 AR P060102914 A ARP060102914 A AR P060102914A AR P060102914 A ARP060102914 A AR P060102914A AR 055072 A1 AR055072 A1 AR 055072A1
Authority
AR
Argentina
Prior art keywords
celiac disease
treatment
tropical
esprue
madcam antibodies
Prior art date
Application number
ARP060102914A
Other languages
English (en)
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of AR055072A1 publication Critical patent/AR055072A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Uso de anticuerpo anti-MAdCAM para la fabricacion de un medicamento para el tratamiento de enfermedad celíaca y/o esprue tropical. También se incluyen procedimientos de tratamiento de enfermedad celíaca y/o esprue tropical usando una cantidad terapéuticamente eficaz de un anticuerpo anti-MAdCAM.
ARP060102914A 2005-07-08 2006-07-06 Uso de anticuerpos anti- madcam para el tratamiento de enfermedad celiaca y esprue tropical AR055072A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69745405P 2005-07-08 2005-07-08

Publications (1)

Publication Number Publication Date
AR055072A1 true AR055072A1 (es) 2007-08-01

Family

ID=37491744

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102914A AR055072A1 (es) 2005-07-08 2006-07-06 Uso de anticuerpos anti- madcam para el tratamiento de enfermedad celiaca y esprue tropical

Country Status (15)

Country Link
US (1) US20100119517A1 (es)
EP (1) EP1904103A2 (es)
JP (1) JP2007016030A (es)
KR (1) KR20080017088A (es)
CN (1) CN101227923A (es)
AR (1) AR055072A1 (es)
AU (1) AU2006268045A1 (es)
BR (1) BRPI0612645A2 (es)
CA (1) CA2613017A1 (es)
IL (1) IL188318A0 (es)
MX (1) MX2008000129A (es)
RU (1) RU2007149268A (es)
TW (1) TW200740845A (es)
WO (1) WO2007007145A2 (es)
ZA (1) ZA200711163B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2362667T3 (es) 2004-01-09 2011-07-11 Pfizer Inc. ANTICUERPOS FRENTE A MAdCAM.
PT2620450T (pt) * 2005-03-08 2018-12-17 Pfizer Prod Inc Composições de anticorpos anti-ctla-4
CA2916283C (en) 2015-01-09 2024-07-02 Pfizer Inc. MADCAM ANTAGONIST DOSING REGIMEN
MA48241A1 (fr) 2017-07-14 2021-03-31 Pfizer Anticorps dirigés contre madcam
AU2024282654A1 (en) 2023-05-30 2025-12-04 Paragon Therapeutics, Inc. Alpha4beta7 integrin antibody compositions and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803904B2 (en) * 1995-09-01 2010-09-28 Millennium Pharmaceuticals, Inc. Mucosal vascular addressing and uses thereof
US6551593B1 (en) * 1995-02-10 2003-04-22 Millennium Pharmaceuticals, Inc. Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam

Also Published As

Publication number Publication date
TW200740845A (en) 2007-11-01
RU2007149268A (ru) 2009-07-10
JP2007016030A (ja) 2007-01-25
CA2613017A1 (en) 2007-01-18
AU2006268045A1 (en) 2007-01-18
WO2007007145A3 (en) 2007-05-31
IL188318A0 (en) 2008-04-13
BRPI0612645A2 (pt) 2010-11-23
US20100119517A1 (en) 2010-05-13
EP1904103A2 (en) 2008-04-02
KR20080017088A (ko) 2008-02-25
MX2008000129A (es) 2008-03-18
WO2007007145A2 (en) 2007-01-18
CN101227923A (zh) 2008-07-23
ZA200711163B (en) 2008-10-29

Similar Documents

Publication Publication Date Title
CY1124144T1 (el) Συνθεσεις και μεθοδοι για θεραπεια εγκεφαλικου επεισοδιου σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης
CY1112277T1 (el) ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ΑΝΤΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
UY29283A1 (es) Anticuerpos ab(beta)usados en mejorar la cognicion
CY1115871T1 (el) Μεθοδοι για την αντιμετωπιση ουρικης αρθριτιδας
CY1111622T1 (el) Ανθρωποποιημενοι ανταγωνιστες anti-cmet
EA200901211A1 (ru) Антигены белка с5 и их применение
CY2017013I1 (el) ΑΝΤΙΣΩΜΑ ΕΝΑΝΤΙΟΝ PDGFR-α ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΟΓΚΩΝ
EA200900040A1 (ru) Молекулы антител, которые связываются с человеческим il-17
CY1110783T1 (el) Μονοκλωνικα αντισωματα κατα αυξητικου παραγοντα ηπατοκυτταρων
AR059922A1 (es) Anticuerpos monoclonales humanizados para el factor de crecimiento de hepatocitos
DOP2017000177A (es) Nuevos anticuerpos anti-cd38 para el tratamiento del cáncer
CY1115700T1 (el) Αντισωματα και ανοσοσυζευγματα αντι-cd79b και μεθοδοι χρησης
AR058182A1 (es) Metodos, composiciones y equipos par el tratamiento de afecciones medicas
DK2109623T3 (da) Cancerbehandling med anti-IL-1-antistoffer
MX2008012754A (es) Composiciones de anticuerpos y metodos para tratamiento de enfermedad neoplastica.
UY29284A1 (es) Anticuerpos ab(beta) humanizados usados en mejorar la cognicion
CY1118760T1 (el) Τροποποιημενα αντισωματα εναντι il-23
CR10730A (es) Anticuerpos agonistas anti notch3 y su uso en el tratamiento de las enfermedades relacionadas con el gen notch3
HUE058777T2 (hu) Monoklonális antitestek a Claudin-18 ellen a rák kezelésére
GT200800098A (es) Anticuerpos anti mn y metodos para su utilización
UA109633C2 (uk) Антитіло людини проти тканинного фактора
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
ECSP088241A (es) Un conjugado citotóxico ca6 antígeno-específico y métodos para utilizar el mismo
WO2008134724A3 (en) Methods for administering anti-il-5 antibodies
CY2022028I1 (el) Εξανθρωπισμενα αντισωματα αντι-cd19 και οι χρησεις τους στην θεραπεια ογκων, μεταμοσχευσης και ασθενειων αυτο-ανοσιας

Legal Events

Date Code Title Description
FA Abandonment or withdrawal